Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Genetics & Genomics

Pharmacogenomic Testing and Warfarin Management

Andrea Maluso
ONF 2015, 42(5), 563-565 DOI: 10.1188/15.ONF.563-565

Warfarin has been used for the prevention of thrombosis for more than 50 years and is the most frequently prescribed vitamin K antagonist in North America. Its mode of action is to prevent vitamin K from converting to vitamin KH2, thereby inhibiting clotting factors.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or